SLC12A5 and amyotrophic lateral sclerosis: We then studied the KCC2 response in injured MNs, identified by labeling the activation transcription factor 3 (ATF3) as a marked of axonal damage (Tsujino et al., 2000), to assess whether KCC2 behave similarly between ALS and axotomized MNs.